Sacubitril/valsartan for treatment of chronic heart failure with reduced ejection fraction. Can all patients benefit? A position statement paper of experts of the Heart Failure Working Group of the Polish Cardiac Society

Ewa Straburzyńska-Migaj; Jadwiga Nessler; Marcin Gruchała; Karol Kamiński; Małgorzata Lelonek; Przemysław Leszek; Katarzyna Mizia-Stec; Piotr Rozentryt; Andrzej Gackowski; Adrian Gwizdała; Ewa A. Jankowska; Piotr Ponikowski

doi:10.5603/KP.2017.0056

Polish Heart Journal (Kardiologia Polska)
Vol 75, No 3 (2017) Sacubitril/valsartan for treatment of chronic heart failure with reduced ejection fraction. Can all patients benefit? A position statement paper of experts of the Heart Failure Working Group of the Polish Cardiac Society

Vol 75, No 3 (2017)

Experts' opinions and Positions papers

Published online: 2017-03-20

View PDF Download PDF file View HTML

Page views 1029

Article views/downloads 439

Get Citation

Connect on Social Media

Sacubitril/valsartan for treatment of chronic heart failure with reduced ejection fraction. Can all patients benefit? A position statement paper of experts of the Heart Failure Working Group of the Polish Cardiac Society

Ewa Straburzyńska-Migaj, Jadwiga Nessler, Marcin Gruchała, Karol Kamiński, Małgorzata Lelonek, Przemysław Leszek, Katarzyna Mizia-Stec, Piotr Rozentryt, Andrzej Gackowski, Adrian Gwizdała, Ewa A. Jankowska, Piotr Ponikowski

DOI: 10.5603/KP.2017.0056

Kardiol Pol 2017;75(3):286-293.

Abstract

Not available

Full content:

View HTML View PDF Download PDF file

Polish Heart Journal (Kardiologia Polska)

About Via Medica Advertising

Bookstore (Ikamed) TVMed

News